Eikon Therapeutics
Developer of a biopharmaceutical platform intended to offer a novel treatment for life-threatening diseases. The company's platform facilitates sensitive identification of compound-protein interaction...
Valuation
$1.9B
Latest known
Share Price
N/A
Total Raised
$1.2B
Last Round
N/A